1. Health
Send to a Friend via Email

Discuss in my forum

Barbara Bradley Bolen, Ph.D.

Linaclotide Gets European Approval As Constella

By November 29, 2012

Follow me on:

Ironwood Pharmaceuticals has reported that their medication linaclotide has received approval from the European Commission for the treatment of IBS-C in adults. The press release does not make any mention of approval of the medication for the treatment of chronic idiopathic constipation, a condition in which the medication has received FDA approval for use in adults. The press release indicated that the medication should be available in Europe in the first half of next year. In the U.S., the medication was supposed to be available by the end of this year. No news on that score yet, but you can count on me to keep you posted!

For more on linaclotide, see:

Related Reading from Dr. Bolen, Your IBS Guide:


"Constella® (linaclotide) approved in Europe for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults" Ironwood Pharmaceuticals Press Release November 28, 2012.

Facebook | Twitter | Google+ | Newsletter Signup | Forum

No comments yet. Leave a Comment
Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>
  1. About.com
  2. Health
  3. Irritable Bowel Syndrome

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.